SYDNEY, Dec. 9, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the first participant was randomized and treated Friday in the United States in the XanaMIA phase 2b /3 ...
Some results have been hidden because they may be inaccessible to you